HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.

Abstract
The aberrant overexpression of Wilms tumor 1 (WT1) in myeloid leukemia plays an important role in blast cell survival and resistance to chemotherapy. High expression of WT1 is also associated with relapse and shortened disease-free survival in patients. However, the mechanisms by which WT1 expression is regulated in leukemia remain unclear. Here, we report that heat shock protein 90 (Hsp90), which plays a critical role in the folding and maturation of several oncogenic proteins, associates with WT1 protein and stabilizes its expression. Pharmacologic inhibition of Hsp90 resulted in ubiquitination and subsequent proteasome-dependant degradation of WT1. RNAi-mediated silencing of WT1 reduced the survival of leukemia cells and increased the sensitivity of these cells to chemotherapy and Hsp90 inhibition. Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2. Collectively, our studies identify WT1 as a novel Hsp90 client and support the crucial role for the WT1-Hsp90 interaction in maintaining leukemia cell survival. These findings have significant implications for developing effective therapies for myeloid leukemias and offer a strategy to inhibit the oncogenic functions of WT1 by clinically available Hsp90 inhibitors.
AuthorsHima Bansal, Sanjay Bansal, Manjeet Rao, Kevin P Foley, Jim Sang, David A Proia, Ronald K Blackman, Weiwen Ying, James Barsoum, Maria R Baer, Kevin Kelly, Ronan Swords, Gail E Tomlinson, Minoo Battiwalla, Francis J Giles, Kelvin P Lee, Swaminathan Padmanabhan
JournalBlood (Blood) Vol. 116 Issue 22 Pg. 4591-9 (Nov 25 2010) ISSN: 1528-0020 [Electronic] United States
PMID20651072 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Benzoquinones
  • HSP90 Heat-Shock Proteins
  • Lactams, Macrocyclic
  • STA 9090
  • Triazoles
  • WT1 Proteins
  • tanespimycin
  • Etoposide
  • Proteasome Endopeptidase Complex
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology)
  • Apoptosis (drug effects)
  • Benzoquinones (pharmacology, therapeutic use)
  • Cell Line, Tumor
  • Etoposide (pharmacology)
  • Female
  • Gene Expression Regulation, Leukemic
  • Gene Silencing
  • HSP90 Heat-Shock Proteins (antagonists & inhibitors, chemistry, metabolism)
  • Humans
  • Lactams, Macrocyclic (pharmacology, therapeutic use)
  • Leukemia, Myeloid (drug therapy, genetics, metabolism)
  • Mice
  • Mice, SCID
  • Proteasome Endopeptidase Complex (metabolism)
  • Protein Interaction Domains and Motifs
  • Protein Structure, Tertiary
  • Triazoles (therapeutic use)
  • WT1 Proteins (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: